Cronos (CRON) Acquisitions (2019)

Cronos' (CRON) quarterly Acquisitions came in at $221.3 million in Q4 2019.

Cronos (CRON) Acquisitions (2019) Analysis & Trends

Cronos' Acquisitions history runs 1 years deep, the most recent figure standing at $221.3 million for Q4 2019.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to $221.3 million in Q4 2019; TTM through Dec 2024 was $221.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $6.0 million, changed N/A from the prior year.
  • Acquisitions was little changed at $221.3 million in Q4 2019 per CRON's latest filing.
  • Across five years, Acquisitions topped out at $221.3 million in Q4 2019 and bottomed at $221.3 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 221.34 Mn